Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.5612
-0.0145 (-2.52%)
Jul 30, 2026, 1:35 PM EDT - Market open
Gelteq Revenue
Gelteq had revenue of 89.30K AUD in the quarter ending December 31, 2025, with 48.92% growth. This brings the company's revenue in the last twelve months to 471.80K, up 153.17% year-over-year. In the fiscal year ending June 30, 2025, Gelteq had annual revenue of 413.13K with 188.27% growth.
Revenue (ttm)
471.80K AUD
Revenue Growth
+153.17%
P/S Ratio
20.46
Revenue / Employee
58,975 AUD
Employees
8
Market Cap
6.28M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 413.13K | 269.82K | 188.27% |
| Jun 30, 2024 | 143.31K | -199.59K | -58.21% |
| Jun 30, 2023 | 342.90K | -29.17K | -7.84% |
| Jun 30, 2022 | 372.07K | 212.20K | 132.73% |
| Jun 30, 2021 | 159.87K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| Sunshine Biopharma | 35.49M |
| cbdMD | 19.98M |
| Sonoma Pharmaceuticals | 19.53M |
| InMed Pharmaceuticals | 4.94M |
| RedHill Biopharma | 286.00K |
| Akanda | 258.08K |
GELS News
- 6 weeks ago - Gelteq Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 6 weeks ago - Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - GlobeNewsWire
- 6 weeks ago - Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - GlobeNewsWire
- 2 months ago - Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - GlobeNewsWire
- 2 months ago - Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - GlobeNewsWire
- 2 months ago - Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA - Accesswire
- 2 months ago - Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - GlobeNewsWire
- 4 months ago - Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million - Accesswire